Paul Turner

This inventor holds 8 USPTO granted patents and 1 EPO patent. Top assignees: Astrazeneca Ab, Astra Zeneca U.k. Limited, Zeneca Limited. Active years: 2001-2016.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Paul Turner. Retrieved from https://idiyas.com/inventor/paul-turner-hv36407d

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 8

% Patents Active = 75.0

EPO Patents = 1 (Patent Applications = 1)

Average Co-Inventor Count = 3.5

ph-index = 3

Forward Citations = 32(Granted Patents)

Location History:

Cheshire, GB (2014)
Macclesfield, GB (2001 - 2015)
Cambridge, GB (2015 - 2016)

Company Filing History:

Astra Zeneca U.k. Limited

Years Active: 2001-2016

Loading Chart...

8 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 9421213 - Chemical compounds (2016-08-23),

2. 9155742 - Chemical compounds (2015-10-13),

3. 8999997 - Chemical compounds (2015-04-07),

4. 8710224 - Heterocyclic compounds as CCR2B antagonists (2014-04-29),

5. 8552004 - Chemical compounds (2013-10-08),

6. 8252802 - Chemical compounds (2012-08-28),

7. 6936610 - Heterocyclic derivatives (2005-08-30),

8. 6300330 - Heterocycle derivatives which inhibit factor Xa (2001-10-09),

Title: Celebrating the Innovations of Inventor Paul Turner

Introduction: Paul Turner, an accomplished inventor based in Macclesfield, GB, has made significant contributions to the field of chemical compounds. With a remarkable portfolio of eight patents, his work impacts both the scientific community and the pharmaceutical industry.

Latest Patents: Among his notable inventions are pyrimidinyl compounds, described in his latest patents. These compounds, represented by Formula (I), and their pharmaceutically acceptable salts, have undergone extensive processes for their preparation. Furthermore, the pharmaceutical compositions containing these compounds are recognized for their therapeutic applications, highlighting Turner's commitment to advancing healthcare solutions.

Career Highlights: Throughout his career, Paul Turner has worked with leading pharmaceutical companies, significantly AstraZeneca AB and Zeneca Limited. His experience with these organizations has allowed him to harness his expertise in chemical innovations, contributing to the successful development of new therapies.

Collaborations: Collaboration has been key to his journey, having worked alongside esteemed colleagues such as Kevin Michael Foote and Johannes Wilhelmus Maria Nissink. Their collective knowledge and skills have enhanced the innovative processes within their projects.

Conclusion: Paul Turner is a noteworthy inventor whose contributions in the realm of chemical compounds continue to resonate within the industry. His eight patents and collaborations reflect a dedication to innovation that not only fosters scientific advancement but also paves the way for future therapeutic applications.

Profile summary based on public USPTO records.